TGA provisionally approves Moderna’s COVID-19 vaccine for use as a booster dose in individuals 12 years and older

TGA

20 October 2022 - On 19 October 2022, the TGA provisionally approved Moderna's COVID-19 vaccine, Spikevax (elasomeran), for use as a booster dose in individuals aged 12 years and older.

This mRNA vaccine is already provisionally approved for immunisation to prevent COVID-19 in individuals aged 6 months and older and as a booster dose for adults aged 18 years and older.

Read TGA News

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Australia , Vaccine , COVID-19